Allamandicin is primarily studied for its potential biological activities, particularly its cytotoxic effects against certain cancer cell lines. It has shown promise in preliminary research as an antiproliferative agent, suggesting possible applications in oncology drug development. The compound may interfere with cell division or induce apoptosis in malignant cells, making it a candidate for further investigation in cancer therapy. Additionally, allamandicin exhibits antimicrobial properties, which could be explored for use in treating resistant bacterial or fungal infections. Due to its natural origin and structural complexity, it also serves as a model compound for synthesizing derivatives with enhanced therapeutic profiles. Research remains in early stages, mostly in vitro, and further studies are needed to evaluate its efficacy and safety in clinical settings.